13% of the participants treated with the combined compound ended up discontinuing the trial, while 10% of the participants treated with semaglutide discontinued, however, none of the participants treated with cagrilintide discontinued their treatment plan indicating that cagrilintide was the most well tolerated by the study participants [2]
Your provider can explain possible benefits and considerations
Recommendation (Evidence Strength: Grade C) Intradetrusor onabotulinumtoxin A may be administered if other treatments have not provided adequate improvement in symptoms and quality of life
If you want a clinician who is tracking that process and can tell you honestly whats available today, whats coming, and whether it makes sense for you, thats the conversation we have here every week
The B12 injection will help increase blood circulation
The injectable form is typically used when oral administration is not feasible or not sufficiently effective
